MA43415A - Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées - Google Patents

Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées

Info

Publication number
MA43415A
MA43415A MA043415A MA43415A MA43415A MA 43415 A MA43415 A MA 43415A MA 043415 A MA043415 A MA 043415A MA 43415 A MA43415 A MA 43415A MA 43415 A MA43415 A MA 43415A
Authority
MA
Morocco
Prior art keywords
modified rna
uridine diphosphate
rna coding
associated uses
diphosphate glucuronosyltransferase
Prior art date
Application number
MA043415A
Other languages
English (en)
Inventor
Christian Cobaugh
Melissa Lasaro
David Osterman
Haren Vasavada
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of MA43415A publication Critical patent/MA43415A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01017—Glucuronosyltransferase (2.4.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA043415A 2015-12-09 2016-12-09 Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées MA43415A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562265174P 2015-12-09 2015-12-09

Publications (1)

Publication Number Publication Date
MA43415A true MA43415A (fr) 2018-10-17

Family

ID=57758709

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043415A MA43415A (fr) 2015-12-09 2016-12-09 Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées

Country Status (4)

Country Link
US (1) US20190307857A1 (fr)
EP (1) EP3386533A1 (fr)
MA (1) MA43415A (fr)
WO (1) WO2017100562A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022500444A (ja) * 2018-09-14 2022-01-04 モダーナティエックス・インコーポレイテッドModernaTX, Inc. クリグラー−ナジャー症候群の治療のためのウリジン二リン酸グリコシルトランスフェラーゼ１ファミリー、ポリペプチドａ１をコードするポリヌクレオチド

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
RS63964B1 (sr) 2005-08-23 2023-03-31 Univ Pennsylvania Rnk koja sadrži modifikovane nukleozide i postupci za njenu upotrebu
EP1962907A2 (fr) 2005-12-21 2008-09-03 Wyeth a Corporation of the State of Delaware Formulations de proteines a viscosite reduite et leurs utilisations
DK3338765T3 (en) 2009-12-01 2019-03-04 Translate Bio Inc STEROID DERIVATIVE FOR THE SUPPLY OF MRNA IN HUMANGENETIC DISEASES
WO2012075040A2 (fr) 2010-11-30 2012-06-07 Shire Human Genetic Therapies, Inc. Arnm pour l'utilisation dans le traitement de maladies génétiques humaines
WO2012129648A1 (fr) 2011-03-25 2012-10-04 University Of Guelph Activation d'expression de protéines de vecteurs de virus adéno-associés
RS63244B1 (sr) 2011-12-16 2022-06-30 Modernatx Inc Kompozicije modifikovane mrna
CA2868391A1 (fr) * 2012-04-02 2013-10-10 Stephane Bancel Polynucleotides comprenant du n1-methyl-pseudouracils et methodes pour les preparer
US20140010861A1 (en) 2012-04-02 2014-01-09 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
WO2013185069A1 (fr) 2012-06-08 2013-12-12 Shire Human Genetic Therapies, Inc. Administration pulmonaire d'arnm à des cellules cibles autres que pulmonaires
LT2922554T (lt) 2012-11-26 2022-06-27 Modernatx, Inc. Terminaliai modifikuota rnr
JP6730193B2 (ja) * 2014-04-25 2020-07-29 ジェネトン 高ビリルビン血症の処置

Also Published As

Publication number Publication date
WO2017100562A9 (fr) 2017-08-03
US20190307857A1 (en) 2019-10-10
EP3386533A1 (fr) 2018-10-17
WO2017100562A1 (fr) 2017-06-15

Similar Documents

Publication Publication Date Title
GB2552618B (en) Waveguide modulator structures
HUE046447T2 (hu) Betonfödém
DK3296597T3 (da) Krydshovedmotor
SG11201708196PA (en) Piling construction management method
MA49684A (fr) Arnm modifié codant une glucose-6-phosphatase et utilisations associées
PL4030014T3 (pl) Wkładka dystansowa ścienna
MA49634A (fr) Arnm modifié codant pour une propionyl-coa-carboxylase et utilisations associées
ITUB20152037A1 (it) Benna frantumatrice
MA43415A (fr) Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées
ITUB20152029A1 (it) Benna frantumatrice
HU4788U (hu) Építõelem-készlet
AU201713207S (en) Concrete Form Spacer
IT201600131099A1 (it) Pannello fonoassorbente perfezionato.
GB201507312D0 (en) Quantum hardened cryptosystem
UA32418S (uk) Молоток
UA32417S (uk) Молоток
PT3341535T (pt) Elementos de espaçamento para armaduras de betão
GB201512552D0 (en) Keys / locks
TWM533106U (en) Improved formwork structure of U-shaped ditch
UA32424S (uk) Зубило
HU5021U (hu) Kötõanyag nélküli falazóelem
FI10998U1 (fi) Putkilapio
UA32861S (uk) Ключ г-подібний
UA32413S (uk) Ключ г-подібний
BR112018004823A2 (pt) Chapa de aço